New guidelines for GLP-1 therapy and obesity treatment Evidence-based nutritional and lifestyle strategies play a pivotal role to address key challenges around GLP-1 treatment of obesity, making clinicians more effective in advancing their patients' health
[1] This incretin hormone plays a crucial role in regulating blood glucose levels, appetite, and overall metabolic health
If people are drinking less sugary soda, companies might try new flavors or sugar free options
However, currently, only Wegovy and Saxenda have been approved for the treatment of obesity, so the market is still in its early stages
Managing weight can be a significant challenge, particularly for men who face unique health challenges related to obesity
In ATTAIN-1, the familiar cluster appeared again: nausea, diarrhoea, constipation, vomiting, indigestion, and abdominal pain, mostly mild to moderate and concentrated during the weeks when the dose was being stepped up